5 news items
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
PLSE
20 May 24
®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation
Pulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFAâ„¢) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
PLSE
16 May 24
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
PLSE
9 May 24
bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company's proprietary
Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
PLSE
2 May 24
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life
Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
PLSE
24 Apr 24
is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company's
- Prev
- 1
- Next